Literature DB >> 30343679

Clinical Neuropathology image 6-2018: Metastasis of breast carcinoma to meningioma.

Sigrid Klotz, Christian Matula, Matthias Pones, Merima Herac, Anna Grisold, Johannes A Hainfellner, Gabor G Kovacs, Ellen Gelpi.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30343679      PMCID: PMC6350239          DOI: 10.5414/NP301150

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


× No keyword cloud information.
We report a case of a 33-year-old woman with history of stage IV breast cancer diagnosed at the age of 30 with metastasis to a meningioma. She presented with progressive headache and a gradual reduction of vision over the course of 10 days. MRI revealed multiple intracranial lesions suspicious of metastases. In two of them, the differential diagnosis with meningiomas was raised. One of the latter tumors compressed the optical nerves (right > left) and the optic chiasm, which indicated immediate microsurgical excision of the tumor. Neuropathological examination revealed two intimately connected neoplastic lesions. One lesion showed features of a meningotheliomatous meningioma, and within it, large epithelial, highly proliferating tumor nests were identified (Figure 1A). The epithelial nests showed strong nuclear immunoreactivity for GATA3 (Figure 1C), supporting an origin from the primary breast carcinoma [1]. In contrast, meningioma cells showed prominent nuclear immunoreaction for progesterone receptor (Figure 1B) and remained negative for GATA3. The diagnosis of a metastasis of a breast carcinoma to a meningotheliomatous meningioma was made.
Figure 1.

A: Hematoxylin & Eosin stained section shows the two different neoplastic components. On the lower left part of the figure, parts of a meningioma with formation of whorls (asterisk), on the upper right part of the figure nests of an epithelial neoplasm. B: Strong nuclear immunoreactivity for progesterone-receptor in the meningioma (asterisk). C: Strong nuclear immunoreactivity of the metastasis for GATA3. Note the negative staining in the meningioma (asterisk and surroundings). All images magnification × 100.

Tumor-to-tumor metastasis has been described before, although it presents a rather uncommon occurrence [1, 2]. Meningiomas are the most common intracranial recipient tumors of tumor-to-tumor metastasis [2, 3]. Breast and lung carcinomas are the most common origin of metastases to other tumors [1, 2, 4]. Different hypotheses to the pathogenesis of malignomas metastasizing into meningiomas have been proposed. First, a high percentage of meningiomas express progesterone receptors, as seen in the present case (Figure 1A), which could be a contributing factor to metastasis formation of breast cancer in meningioma [5]. In addition, the rich vascularization and the drainage by the dural sinus could facilitate hematogenous spread into the meningioma [1]. Moreover, the meningioma might provide an ideal environment for other tumors to grow in, not only because of an ideal nutritional microenvironment, but also because of an altered immunological condition and a non-competitive setting due to the slow growth of the meningioma [4, 6]. And finally, the observation of a metastasis of a pulmonary carcinoma in the same localization where a meningioma had been removed 11 months earlier suggests that there might be other advantageous factors in the surroundings of meningiomas [7]. This case presents a special constellation of a patient with two different rare occurrences: a young age for suffering from breast cancer and the metastasis to a meningioma. Whether there is a common link between these two situations remains unclear, as well as the exact mechanisms involved in tumor-to-tumor metastasis. Further studies are needed to better characterize this phenomenon.

Funding

There was no specific funding for this study.

Conflict of interest

The authors declare no conflict of interest.
  7 in total

1.  A unique case of intracranial metastasis from lung carcinoma.

Authors:  S Y el Sharouni; M W Berfelo; P H Theunissen; J J Jager; J M de Jong
Journal:  Clin Neurol Neurosurg       Date:  1993-09       Impact factor: 1.876

2.  Papillary thyroid carcinoma metastasizing to anaplastic meningioma: an unusual case of tumor-to-tumor metastasis.

Authors:  Sumit Das; Navjot Chaudhary; Lee-Cyn Ang; Joseph S Megyesi
Journal:  Brain Tumor Pathol       Date:  2017-06-09       Impact factor: 3.298

Review 3.  Metastatic spread of systemic neoplasms to central nervous system tumors: review of the literature and case presentation of esophageal carcinoma metastatic to meningioma.

Authors:  Bertram Richter; Lakshmi Harinath; Cunfeng Pu; Kristen Stabingas
Journal:  Clin Neuropathol       Date:  2017 Mar/Apr       Impact factor: 1.368

4.  Metastasis of lung carcinoma to intracranial meningioma. Case report and review of literature.

Authors:  M Conzen; H Sollmann; R Schnabel
Journal:  Neurochirurgia (Stuttg)       Date:  1986-09

5.  Is progesteron receptor status really a prognostic factor for intracranial meningiomas?

Authors:  A Celal Iplikcioglu; Mustafa Aziz Hatiboglu; Erdinc Ozek; Deniz Ozcan
Journal:  Clin Neurol Neurosurg       Date:  2014-07-01       Impact factor: 1.876

Review 6.  Systemic cancer metastasis in a meningioma: report of two cases and review of the literature.

Authors:  Michele Lanotte; Franco Benech; Pier Paolo Panciani; Paola Cassoni; Alessandro Ducati
Journal:  Clin Neurol Neurosurg       Date:  2008-10-19       Impact factor: 1.876

7.  Tumor-to-tumor metastasis to the central nervous system.

Authors:  Hidehiro Takei; Suzanne Z Powell
Journal:  Neuropathology       Date:  2008-07-18       Impact factor: 1.906

  7 in total
  2 in total

Review 1.  Metastases to meningioma-review and meta-analysis.

Authors:  Naama Turner; Andrew H Kaye; Iddo Paldor
Journal:  Acta Neurochir (Wien)       Date:  2021-01-03       Impact factor: 2.216

2.  Meningioma as the host for metastatic breast cancer: A rare occurrence with important therapeutic impact.

Authors:  Mohammad Hosseinzadeh; Seyed Mehdi Ketabchi; Seyed Ali Ahmadi; Kasra Hendi; Maysam Alimohamadi
Journal:  Surg Neurol Int       Date:  2021-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.